1. Home
  2. LSH vs CARA Comparison

LSH vs CARA Comparison

Compare LSH & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSH
  • CARA
  • Stock Information
  • Founded
  • LSH 2018
  • CARA 2004
  • Country
  • LSH United States
  • CARA United States
  • Employees
  • LSH N/A
  • CARA N/A
  • Industry
  • LSH
  • CARA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSH
  • CARA Health Care
  • Exchange
  • LSH NYSE
  • CARA Nasdaq
  • Market Cap
  • LSH 18.0M
  • CARA 16.7M
  • IPO Year
  • LSH 2024
  • CARA 2014
  • Fundamental
  • Price
  • LSH $2.46
  • CARA $0.46
  • Analyst Decision
  • LSH
  • CARA Hold
  • Analyst Count
  • LSH 0
  • CARA 3
  • Target Price
  • LSH N/A
  • CARA $1.00
  • AVG Volume (30 Days)
  • LSH 43.2K
  • CARA 3.4M
  • Earning Date
  • LSH 02-01-2025
  • CARA 11-14-2024
  • Dividend Yield
  • LSH N/A
  • CARA N/A
  • EPS Growth
  • LSH N/A
  • CARA N/A
  • EPS
  • LSH N/A
  • CARA N/A
  • Revenue
  • LSH $18,248,233.00
  • CARA $8,686,000.00
  • Revenue This Year
  • LSH N/A
  • CARA N/A
  • Revenue Next Year
  • LSH N/A
  • CARA N/A
  • P/E Ratio
  • LSH N/A
  • CARA N/A
  • Revenue Growth
  • LSH 28.38
  • CARA N/A
  • 52 Week Low
  • LSH $2.10
  • CARA $0.23
  • 52 Week High
  • LSH $5.37
  • CARA $1.15
  • Technical
  • Relative Strength Index (RSI)
  • LSH N/A
  • CARA 79.54
  • Support Level
  • LSH N/A
  • CARA $0.23
  • Resistance Level
  • LSH N/A
  • CARA $0.48
  • Average True Range (ATR)
  • LSH 0.00
  • CARA 0.06
  • MACD
  • LSH 0.00
  • CARA 0.02
  • Stochastic Oscillator
  • LSH 0.00
  • CARA 80.82

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Share on Social Networks: